Investigation the effect of aqueous extract of salvia mirzayanii in treatment of diabetes

Phase 2

• Conditions: Type 2 diabetes disease based on WHO guide line.; Non insulin dependent diabetes

• Registration Number: IRCT2015122725712N1
• Lead Sponsor: Hormozgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Inclusion criteria include
patients with the age range between 19 and 65 years;
patients having diabetes mellitus based on the guideline of the WHO 1999;
Patients with BMI were >19 Kg/m2 and <30 Kg/m2;
Patients with BMI > 30, who have not any other diseases;
Patients without insulin therapy and any other complications;
Patients with HbA1C > 7% and blood sugar> 7 mmol/ l

Exclusion criteria’s include
pregnant women, or women wanted to become Pregnant;

Patients with active infections or hepatitis C, B, HIV or TB (or in TB therapy);
Cancer patients (except patients with skin cancer);
patients using steroids such as prednisone for the treatment of a chronic disease;
patients smoking cigarettes and drinking alcohol;
patients with blood pressure higher than 160/90;
usage of contraceptive pill by women;
Moreover, patients with malabsorption; chronic diarrhea; liver and kidney diseases; ischemia heart failure; anemia; heart attack; peripheral vascular disease and diabetic nephropathy are excluded from the study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1C. Timepoint: in the beginnig of study and after 3 months of intervention. Method of measurement: by kit.;Levels of liver enzymes. Timepoint: beginning of the study and after 3 months of intervention. Method of measurement: by kit.;Lipid profile. Timepoint: beginning of the study and after 3 months of intervention. Method of measurement: by kit.;Fasting Blood Sugar(FBS). Timepoint: in the beginnig of the study and after 3 months of intervention. Method of measurement: by kit.

Secondary Outcome Measures

Name	Time	Method
BMI. Timepoint: in the beginnig of the study and after 3 months of intervention. Method of measurement: Balance.